Summary
The product Ment (100 mg), submitted by MuscleCandy, underwent qualitative and quantitative analysis. The batch is identified as Lot 1003, and the analysis detected a concentration of 89.02 mg/ml of Trestolone Acetate, which is 10.98% below the labeled claim of 100 mg/ml.
The analysis was conducted on 25 April 2024, following the sample receipt on 24 April 2024.
Detailed Report
Product Information
- Manufacturer: MuscleCandy
- Sample: Ment (100 mg)
- Active Ingredient: Trestolone Acetate
- Batch Number: Lot 1003
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Processing and Analysis
- Task Number: #41402
- Testing Ordered: 19 April 2024
- Sample Received: 24 April 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: MuscleCandy
- Analysis Paid For By: MuscleCandy
Testing Results
- Claimed Specification: 100 mg/ml
- Measured Concentration: 89.02 mg/ml
- Accuracy: 89.02% (10.98% below label claim)
- Variance: -10.98%
Verification Details
- Verification URL: https://janoshik.com/tests/41402_P4MUQRMD1JN8
Evaluation and Insights
The analysis reveals a significant deviation of -10.98%, suggesting that the detected concentration falls notably below the labeled claim. This variance exceeds typical acceptable limits and may indicate potential manufacturing inconsistencies or degradation during storage.
Conclusion
The lab analysis of Ment (100 mg) detected a 89.02 mg/ml concentration of Trestolone Acetate, indicating a -10.98% deviation below the label claim. This result may warrant further investigation or verification.
Disclaimer
This report is provided for educational and harm reduction purposes. Product submissions may involve inherent biases, and independent verification is recommended for critical evaluations.
